Early Access to Medicines Scheme (EAMS) Consultation
The MHRA hosted a public consultation on a proposed statutory instrument for the Early Access to Medicines Scheme (EAMS) from the 6th of August to 17th September 2021. The consultation was carried out to obtain the views from patients, healthcare professionals, businesses involved in EAMS manufacture or supply, and the wider public.
Read the news from Medicines and Healthcare products Regulatory Agency updated on 2 February 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (15 mars 2022). Early Access to Medicines Scheme (EAMS) Consultation. ELSIBI. Consulté le 18 février 2026 à l’adresse https://doi.org/10.58079/o5wh





